Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update
- Conditions
- Dengue Virus Infection
- Interventions
- Other: No intervention
- Registration Number
- NCT04170140
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Brief Summary
The primary objective of the study is to evaluate the effectiveness of additional risk minimization measures material by assessing the knowledge and understanding of healthcare professionals regarding the key safety messages provided in the material.
The secondary objective of the study is to evaluate if healthcare professionals know Dengvaxia product information, namely, age indication and contraindications.
- Detailed Description
The study is a cross-sectional Survey. Study data are collected through a questionnaire.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Prescribers of Dengvaxia No intervention Healthcare professionals who are current or past prescribers of Dengvaxia
- Primary Outcome Measures
Name Time Method Healthcare professionals' knowledge and understanding of key safety messages provided in risk minimization measures materials Day 0 Knowledge and understanding of key safety messages are assessed through a questionnaire
- Secondary Outcome Measures
Name Time Method Healthcare professionals' knowledge of Dengvaxia product information Day 0 Knowledge of Dengvaxia product information (age indication and contraindications) is assessed through a questionnaire
Trial Locations
- Locations (1)
Real World Evidence Solutions IQVIA
🇫🇷La Defense, France